Use of prostate specific antigen to predict drug response
CN1656379A
Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
US6514713B1
Methods of detecting BRCA1 mutations
US7659073B2
Forms of prostate specific antigens and methods for their detection
US7288636B2
Forms of prostate specific antigens and methods for their detection
WO0100798A2
Cloning and expressing of human cathepsin k in mammalian cells
WO0022437A1
Prognostic method for anti-resorptive treatment
US6423503B1
Forms of free prostate-specific antigen (PSA) and their association with prostate tissues from prostate peripheral zone and transition zone
US6482599B1
Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
US6284873B1
Complex of human kallikrein 2 (hK2) and protease inhibitor-6 (PI-6) in prostate tumor tissue and methods of using the complex
AU7166898A
Forms of prostate specific antigen and methods for their detection
US6103237A
Stable variant hK2 polypeptide
WO9426772A1
Separation of anti-metal chelate antibodies
WO9425609A1
Method for creating optimized regulatory regions affecting protein expression and protein trafficking
US5879881A
Solid phase system for use in ligand-receptor assays
ZA9308243B
Altered affinity polypeptides of metal chelate binding antibodies
EP0583894A2
Method of immobilizing and orienting molecules by use of metal chelating moieties to facilitate atomic force microscopy of proteins and molecular scale manipulation
IL106425D0
Chimeric antibodies directed against human carcinoembryonic antigen
